Nicotine decreases the cytotoxicity of doxorubicin towards MCF-7 and KB-3.1 human cancer cells in culture

The harmful effects of tobacco use and nicotine are well known. There is strong epidemiological evidence for smoking as a risk factor for cancer of the lung and oral cavity. The evidence for second-hand smoke as a risk factor for breast cancer is rapidly accumulating. The anthracycline doxorubicin i...

Full description

Saved in:
Bibliographic Details
Published inJournal of the National Medical Association Vol. 99; no. 4; pp. 319 - 327
Main Authors YANFEI ZHOU, XINBIN GU, ASHAYERI, Ebrahim, RENSHU ZHANG, SRIDHAR, Rajagopalan
Format Journal Article
LanguageEnglish
Published Thorofare, NJ Slack 01.04.2007
Elsevier Limited
National Medical Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The harmful effects of tobacco use and nicotine are well known. There is strong epidemiological evidence for smoking as a risk factor for cancer of the lung and oral cavity. The evidence for second-hand smoke as a risk factor for breast cancer is rapidly accumulating. The anthracycline doxorubicin is used in the treatment of many types of malignancies, including breast cancer. The effect of nicotine on doxorubicin toxicity was evaluated in MCF-7 and KB-3.1 cancer cell cultures. Nicotine partially inhibited doxorubicin toxicity towards MCF-7 and KB-3.1 cells, as judged by clonogenicity and flow cytometry assays. Flow cytometric analysis showed that < 10% of cells treated with doxorubicin underwent apoptosis, while necrosis was the major mode of cell death. Inhibition of apoptosis and necrosis in cancer cells by nicotine can diminish the effectiveness of doxorubicin in cancer therapy.
ISSN:0027-9684
1943-4693